Key result
Binding of IGF-1 to the intrinsically disordered linker domain of human IGFBP2 significantly alters its dynamics and increases flexibility, potentially explaining IGF-dependent modulation of proteolysis.
Why the study?
Functional regulation via conformational dynamics is well known in structured proteins but less well characterized in intrinsically disordered proteins and their complexes.
The study identifies a dynamic regulatory mechanism in the human IGF system where IGF-1 binding increases the flexibility of the hIGFBP2 linker domain, potentially informing the design of IGFBP analogs for cancer therapy.
Answers are grounded in this paper and cite their sources.
May inform IGFBP2-targeted strategies; leaves open clinical translation pending functional validation.
Functional regulation via conformational dynamics is well known in structured proteins but less well characterized in intrinsically disordered proteins and their complexes. Using NMR spectroscopy, we have identified a dynamic regulatory mechanism in the human insulin-like growth factor (IGF) system involving the central, intrinsically disordered linker domain of human IGF-binding protein-2 (hIGFBP2). The bioavailability of IGFs is regulated by the proteolysis of IGF-binding proteins. In the case of hIGFBP2, the linker domain (L-hIGFBP2) retains its intrinsic disorder upon binding IGF-1, but its dynamics are significantly altered, both in the IGF binding region and distantly located protease cleavage sites. The increase in flexibility of the linker domain upon IGF-1 binding may explain the IGF-dependent modulation of proteolysis of IGFBP2 in this domain. As IGF homeostasis is important for cell growth and function, and its dysregulation is a key contributor to several cancers, our findings open up new avenues for the design of IGFBP analogs inhibiting IGF-dependent tumors.
No takes yet. Share an insight, caveat, or question.
Jaipuria et al. (2022) studied this question. IGF-1 binding was evaluated on Conformational dynamics and flexibility of the linker domain of hIGFBP2. Binding of IGF-1 to the intrinsically disordered linker domain of human IGFBP2 significantly alters its dynamics and increases flexibility, potentially explaining IGF-dependent modulation of proteolysis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: